πŸ‡ΊπŸ‡Έ FDA
Patent

US 12168059

Trimeric peptides for antisense delivery

granted A61KA61K47/549A61K47/64

Quick answer

US patent 12168059 (Trimeric peptides for antisense delivery) held by Sarepta Therapeutics, Inc. expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue Dec 17 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K47/549, A61K47/64, A61K47/645, A61K47/6455